“Digital Pathology Market Worth $631.43 Million in 2019 “, says Visiongain report

19 December 2019
Pharma

Visiongain’s new report the Digital Pathology Market Report 2019-2029: Forecasts by Product (Scanner, Software, Communication System), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies), plus analysis of leading companies indicates that the global Digital Pathology market will attain $1,796.4 million revenue by 2029.

Global Digital Pathology market is expected to grow on account of increasing usage in drug development and companion diagnostics. The market is expected to grow at a healthy CAGR of 11.02% over the projected period. In addition, an increase in cancer incidence, an increase in the workload of pathologists, and an ever-increasing number of clinical and pre-clinical studies are other significant considerations attributable to the development of the digital pathology industry, and comparable trends are anticipated to reinforce the market concentration of Digital Pathology over the projected period.

Furthermore, the growing geriatric population prone to chronic circumstances is also anticipated to increase demand for sophisticated diagnostic methods. Chronic illnesses can be ascribed to elevated mortality rates, according to a research released in Medscape. It becomes essential to opt for sophisticated diagnostic and imaging options due to the elevated incidence of cardiovascular diseases.

In 2019, North America Digital Pathology market accounted for more than 30% of overall market share. Continuous deployment of R&D investments, supporting public projects related to the development of sophisticated systems, increasing digital imaging acceptance, and the existence of significant players are important contributing factors expected to boost market penetration of Digital Pathology over the forecast period.

The Asia Pacific is anticipated to grow with the fastest growth rate owing to growing penetration of digital imaging in developing economies like India, Japan and China, investments in the medical & healthcare technology field, and the presence of untapped opportunities will offer lucrative growth for digital pathology market in coming years.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

 

Recent News

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

Read

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

Read

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

Read

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever